Trials / Active Not Recruiting
Active Not RecruitingNCT06762470
Prognostic Value of CD4/CD8 Ratio in Patients with Nasopharyngeal Carcinoma
Prognostic Value of Pretreatment Peripheral Circulating Lymphocyte CD4/CD8 Ratio in Patients with Non-metastatic Nasopharyngeal Carcinoma: a Multi-center Prospective Observational Study
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 325 (estimated)
- Sponsor
- Jiangxi Provincial Cancer Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
In our previous retrospective study, we identified circulating immune cell counts and the CD4/CD8 ratio as significant prognostic markers in nasopharyngeal carcinoma. Building on these findings, this study aims to conduct a multi-center prospective observational study to evaluate the prognostic value of the circulating lymphocyte CD4/CD8 ratio in nasopharyngeal carcinoma patients prior to treatment.
Conditions
- Histopathological Diagnosis of Nasopharyngeal Carcinoma
- Patients with Nasopharyngeal Carcinoma Without Distant Metastases After AJCC/UACC 8th Edition
Timeline
- Start date
- 2025-01-01
- Primary completion
- 2028-12-31
- Completion
- 2029-12-31
- First posted
- 2025-01-07
- Last updated
- 2025-01-09
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06762470. Inclusion in this directory is not an endorsement.